[Form 4] Bio-Techne Corp. Insider Trading Activity
Rhea-AI Filing Summary
Bio-Techne Corp. (TECH) insider William Geist reported multiple equity transactions on 08/15/2025 reflecting compensation vesting and a small sale. The filing shows the acquisition of 2,623 common shares via vested restricted stock units at $0, and a disposition of 803 shares sold at $53.60, leaving 15,112 shares beneficially owned after the sale. The report also lists numerous outstanding stock options and performance-based awards, including 24,758 newly acquired stock options exercisable at $53.60 with an 08/15/2035 expiration, other options at strike prices from $74.91 to $100.39, and several restricted and performance RSU pools totaling tens of thousands of shares that vest on various future dates if conditions are met. Transactions were signed by an attorney-in-fact on 08/19/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Mostly routine equity compensation and vesting; awards align executive pay with long-term performance.
The Form 4 indicates standard executive compensation activity: vesting of restricted stock units and grants or reporting of multiple option tranches with staggered vesting and performance conditions. Material elements include the conversion of RSUs into 2,623 shares and the reporting of large pools of performance RSUs and options that extend to 2035, which suggests multi-year retention incentives. The small sale of 803 shares at $53.60 appears to be a minor liquidity action and does not materially alter overall ownership. Overall, these items are governance-typical and aimed at alignment and retention rather than signaling a corporate event.
TL;DR: No material shift in ownership or control; transactions are compensation-related and unlikely to affect valuation directly.
The reporting shows beneficial ownership remaining at 15,112 shares after a modest sale. Significant outstanding derivative positions are detailed: for example, 24,758 options at a $53.60 strike expiring 08/15/2035 and other option tranches aggregating over 100,000 underlying shares across strikes from $53.60 to $100.39. Because many awards are time- or performance-vested, the immediate dilution risk is remote and tied to future vesting and performance certification. The filing lacks any indication of extraordinary transfers or corporate actions that would be material to investors today.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,623 | $0.00 | -- |
| Grant/Award | Performance Restricted Stock Units | 19,355 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 9,678 | $0.00 | -- |
| Grant/Award | Stock Options (Right to Buy) | 24,758 | $0.00 | -- |
| Exercise | Common Stock | 2,623 | $0.00 | -- |
| Tax Withholding | Common Stock | 803 | $53.60 | $43K |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Performance Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026. Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. 9,911 restricted stock units vest on 11/1/2025. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 2,623 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027. Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.
